key: cord-0839906-kaqee8br authors: Campos, Oscar A.; Attar, Narsis; Cheng, Chen; Vogelauer, Maria; Mallipeddi, Nathan V.; Schmollinger, Stefan; Matulionis, Nedas; Christofk, Heather R.; Merchant, Sabeeha S.; Kurdistani, Siavash K. title: A pathogenic role for histone H3 copper reductase activity in a yeast model of Friedreich’s ataxia date: 2021-12-17 journal: Science advances DOI: 10.1126/sciadv.abj9889 sha: 095bc089b84c1425d29133c272d6f88ff986c643 doc_id: 839906 cord_uid: kaqee8br Disruptions to iron-sulfur (Fe-S) clusters, essential cofactors for a broad range of proteins, cause widespread cellular defects resulting in human disease. A source of damage to Fe-S clusters is cuprous (Cu(1+)) ions. Since histone H3 enzymatically produces Cu(1+) for copper-dependent functions, we asked whether this activity could become detrimental to Fe-S clusters. Here, we report that histone H3–mediated Cu(1+) toxicity is a major determinant of cellular functional pool of Fe-S clusters. Inadequate Fe-S cluster supply, due to diminished assembly as occurs in Friedreich’s ataxia or defective distribution, causes severe metabolic and growth defects in Saccharomyces cerevisiae. Decreasing Cu(1+) abundance, through attenuation of histone cupric reductase activity or depletion of total cellular copper, restored Fe-S cluster–dependent metabolism and growth. Our findings reveal an interplay between chromatin and mitochondria in Fe-S cluster homeostasis and a potential pathogenic role for histone enzyme activity and Cu(1+) in diseases with Fe-S cluster dysfunction. The ancient and ubiquitous iron-sulfur (Fe-S) clusters (1) function as prosthetic groups in many enzymes in diverse metabolic and informational processes (2) . The importance of Fe-S clusters to life is evidenced by the pathological consequences associated with their loss of function. For example, Friedreich's ataxia (FRDA) is a progressive, neurodegenerative disease in humans caused by mutations in the FXN gene encoding frataxin (3), a mitochondrial protein important for the assembly of Fe-S clusters (4) . The proteins involved in the cellular assembly of Fe-S clusters, which begins in mitochondria, are evolutionarily conserved across eukaryotes (2, (5) (6) (7) . In the budding yeast, Saccharomyces cerevisiae, the homolog of frataxin, Yfh1, also plays an important role in Fe-S cluster assembly in mitochondria (8, 9) . Loss of Yfh1 results in diminished Fe-S cluster abundance, impairing activities of Fe-S cluster-dependent proteins and pathways. These include aconitase activity (10, 11) and syntheses of certain amino acids such as lysine and glutamate (12, 13) . The net supply of Fe-S clusters depends on the balance between production in the mitochondria and degradation at various downstream stages and locations. The need to maintain this supply is compounded by the vulnerability of Fe-S clusters to damage, including by oxidative stress (14) (15) (16) and reduced copper (Cu 1+ ) ions (17) . In addition to potentially causing oxidative stress (18, 19) , the propensity of Cu 1+ ions to interact with cysteine sulfhydryl groups with high affinity (20) allows Cu 1+ to directly compete with Fe-S clusters for protein binding sites (21) . Thus, Cu 1+ ions can impair Fe-S cluster assembly, delivery, or stability in various enzymes (21, 22) even under anaerobic conditions (17) . This notion is bolstered by the finding that overexpression of Yah1 in yeast, a protein critical for the assembly of the Fe-S clusters in the mitochondria, resulted in resistance to highly elevated copper abundance (23) . These considerations suggested that production of Fe-S clusters might be counterbalanced by Cu 1+ -induced damage, placing the homeostasis of Fe-S clusters under the influence of Cu 1+ ions. We reasoned that when Fe-S cluster assembly is impaired, such as in FRDA in humans or following the loss of Yfh1 in yeast, even physiologic levels of Cu 1+ could become toxic as cells cannot maintain sufficient Fe-S cluster production to counteract Cu 1+ -induced damage. In turn, depletion of Cu 1+ might mitigate the cellular dysfunction resulting from the loss of Fe-S cluster assembly by decreasing the degradation of Fe-S clusters, effectively increasing the availability of functional Fe-S clusters albeit at a lower level than normal conditions (fig. S1). We recently discovered that the eukaryotic histone H3 is a cupric reductase (24) , catalyzing electron transfer and reduction of cupric ions (Cu 2+ ) to Cu 1+ . In yeast, mutation of the histidine-113 residue of histone H3 to asparagine (H3H113N), a key Cu 2+ -binding residue, resulted in diminished Cu 1+ abundance and impaired function of copper-dependent processes, such as mitochondrial respiration and superoxide dismutase function. Considering the potential toxicity of Cu 1+ , however, our findings raised the possibility that histone H3-mediated Cu 1+ production could result in detrimental effects to the pool of Fe-S clusters, especially when Fe-S cluster supply is inadequate. In this study, we found that the various cellular defects resulting from Yfh1 depletion are rescued by diminishing histone cupric reductase activity. Fe-S cluster-dependent function is also recovered by total cellular copper depletion, supporting the conclusion that Cu 1+ production by histone H3 impairs Fe-S cluster function. Our findings suggest that when Fe-S cluster production is compromised, the threshold for copper toxicity decreases, making the physiologic levels of Cu 1+ a liability. Decrease of Cu 1+ levels, including inhibition of the histone H3 copper reductase activity, might therefore represent a previously unrecognized therapeutic strategy for diseases caused by the dysfunction of Fe-S clusters, such as FRDA. The H3H113N mutation in yeast decreases the Cu 1+ pool and diminishes copper utilization for copper-dependent processes without affecting the total intracellular levels of copper (24) . We reasoned that this same mutation might provide resistance against Cu 1+ toxicity. To test this, we introduced the H113N mutation in the two chromosomal copies of the histone H3 gene to generate the yeast strain H3 H113N . Despite its somewhat slower growth, this strain grew better than wild type (WT) in fermentative media containing toxic levels of copper (Fig. 1A) . We considered whether resistance to elevated copper depended on the metallothionein, Cup1, which limits toxicity by sequestering excess intracellular Cu 1+ (25, 26) . However, H3 H113N still displayed substantial resistance to copper toxicity relative to WT when Cup1 was inactivated (F8stop) (fig. S2 ). These results are consistent with decreased intracellular Cu 1+ abundance in H3 H113N resulting in less damage by copper. We next hypothesized that when Fe-S cluster assembly is compromised, diminishing histone cupric reductase activity, which decreases Cu 1+ abundance (24) , should mitigate the ensuing cellular defects, enabling cells to cope with decreased Fe-S cluster production ( fig. S1 ). Deletion of most members of the mitochondrial Fe-S cluster assembly complex is lethal in yeast, except for YFH1. Deletion of YFH1 (yfh1) results in severe growth defects in rich fermentative synthetic complete (SC) medium due to various underlying deficiencies ( Fig. 1B) (8, 27) . The H3H113N mutation substantially rescued the severe growth defect of yfh1 (Fig. 1B) . Although yfh1 suffered severe growth defects, individual clones of this strain displayed a relatively high probability of spontaneous recovery of their growth defects over the course of a few days following YFH1 deletion. This suggests a high likelihood of clones acquiring secondary mutations or other adaptations to cope with the disruption of Fe-S cluster homeostasis. Loss of Yfh1 can result in nuclear genome instability (27) . To avoid this complication, we instead turned to a conditional transcriptional shutoff approach to deplete cells of Yfh1. We replaced the endogenous promoter of YFH1 with the GAL1 promoter, which is active in galactose-containing media but enables robust suppression of gene expression when cells are grown in the presence of glucose. This approach also allows examination of the time-dependent deterioration of function when Yfh1 is depleted. Transcriptional shutoff of YFH1 expression (YFH1-off) resulted in essentially complete depletion of Yfh1 protein after 1 day ( fig. S3A ) and a corresponding minor growth defect in SC (Fig. 1C) . However, prolonged growth in the absence of YFH1 expression revealed a gradually worsening defect in SC in two different yeast strains (Fig. 1C, fig. S3B , and table S1). The growth defect of YFH1-off cells was exacerbated in media with substantially less amino acids (i.e., minimal medium) likely due to increased demand for Fe-S clusters for amino acid biosynthesis ( fig. S3B and see below). H3H113N substantially prevented this gradual growth deterioration in fermentative SC or minimal medium, consistent with diminished toxicity of Cu 1+ to Fe-S clusters ( Fig. 1C and fig. S3B ). Similarly, introduction of the H113Y or H113N mutation (24) in only one copy of the histone H3 gene (i.e., HHT2) was sufficient to prevent the growth defect of YFH1-off in SC medium ( fig. S3C ). Reverting the HHT2-H113N mutation to the WT sequence (i.e., N113H) suppressed the rescue, corroborating that the histone H3 mutation accounts for the protective effect ( fig. S3D ). To determine whether H3H113N could prevent the deterioration resulting from disruptions to Fe-S clusters more generally, we similarly repressed the expression of either GRX5 or ATM1 with the GAL1 promoter (GRX5-off and ATM1-off, respectively). Grx5 and Atm1 function downstream of Yfh1 in the transfer of Fe-S clusters to target proteins in the mitochondria and in the cytoplasm, respectively (28) (29) (30) . Similar to the effect of Yfh1 depletion, GRX5-off and ATM1-off gradually deteriorated over time, but H3H113N substantially prevented this growth defect (Fig. 1, D and E) . These results suggest that H3H113N did not merely compensate for the specific loss of Yfh1, but instead, it more generally prevented the dysfunction when Fe-S cluster homeostasis was disrupted. Depletion of Yfh1 may affect most, if not all, Fe-S cluster-dependent processes in the cell. These processes include the synthesis of certain amino acids that depend on enzymes containing Fe-S clusters (12, (30) (31) (32) (33) . All 20 amino acids are highly abundant in SC, which obviates the need for amino acid synthesis. We therefore gradually decreased the abundance of amino acids in SC and observed a corresponding gradual exacerbation of growth defects in the YFH1-off strain, even after a single day of Yfh1 shutoff ( Fig. 2A and fig. S3B ). This is consistent with an increased demand for Fe-S clusters for amino acid synthesis, thereby accentuating the deficiencies of YFH1-off. As in rich medium, the H3H113N mutation rescued the deterioration of growth in YFH1-off caused by amino acid limitation ( Fig. 2A) . With complete depletion of all amino acids, and thus when demand for Fe-S clusters would be highest, even H3H113N could not prevent the severe growth defect ( Fig. 2A) . This is likely because, even with decreased Cu 1+ -induced damage in H3 H113N , the total Fe-S supply remains below the threshold required to sustain sufficient amino acid synthesis. Fe-S cluster-containing enzymes participate in the syntheses of eight amino acids: methionine, cysteine, leucine, isoleucine, valine, lysine, glutamate, and glutamine. Syntheses of the others are not directly dependent on Fe-S clusters. Consistent with this, supplementation with eight amino acids, the syntheses of which are not dependent on Fe-S clusters, did not alleviate the growth defects of YFH1-off. In contrast, supplementation of amino acid-depleted media with only the eight Fe-S cluster-dependent amino acids restored growth of YFH1-off to the level displayed in complete medium (Fig. 2B) . Together, these findings indicate that the growth defect of YFH1-off when amino acids were depleted was due to the diminished function of the Fe-S cluster-containing enzymes for synthesis of specific amino acids and that diminishing copper reductase activity of histone H3 restores the function of these enzymes. We further examined whether removal of Fe-S cluster-dependent amino acids individually from otherwise replete medium would be sufficient to worsen the growth defect of YFH1-off. Removal of lysine, glutamate, or leucine resulted in diminished growth of YFH1-off ( Fig. 2C and fig. S4A ). This confirms that the synthesis of even a single amino acid can alone place increased demands for Fe-S clusters and exacerbate the growth defect of the YFH1-off strain. We focused on lysine and glutamate as test cases for Fe-S clusterdependent function. The removal of lysine and glutamate (SC-lys-glu) Fig. 2. H3H113N restores Fe-S cluster-dependent cellular processes. (A) Spot test assays in glucose-containing media with gradually decreasing amounts of all 20 amino acids. Baseline (i.e., 1×) concentration of each amino acid is 85.6 mg/liter with some exceptions (see Materials and Methods). (B) Spot test assay with amino acid-depleted media ± 80 mg/liter of each of the amino acids that are either not dependent [non-Fe-S amino acids (AAs)] or dependent (Fe-S amino acids) on Fe-S cluster-containing enzymes. (C) Spot test assays with SC medium lacking lysine or glutamate. (D) 55 Fe content of immunoprecipitated (IP) Aco1-myc, with representative Western blot shown above. Bars show mean scintillation counts per minute (cpm), and each dot is an independent experiment (n = 3). (E) Aconitase activity assay using whole-cell extracts, with representative loading control Western blot shown above. Bars show mean activity relative to the matched WT or H3 H113N , and each dot is an independent experiment (n = 3). (F) Spot test assays in rich medium containing either glucose (SC) or ethanol and glycerol (SCEG). (G) Spot test assays in SC with or without MMS. substantially diminished growth of the YFH1-off strain almost as much as 100-fold depletion of all 20 amino acids (Fig. 2C ). Similar to other conditions, decreased Cu 1+ production in H3 H113N , as well as the HHT2 H113N , substantially prevented severe growth defects due to reduced lysine and glutamate syntheses resulting from diminishment ( Fig. 2C and fig. S4B ) or complete loss of Yfh1 ( fig. S4C ). The ancient and conserved mitochondrial aconitase catalyzes the isomerization of citrate to isocitrate in the tricarboxylic acid cycle, which, in turn, contributes to glutamate synthesis (13) . Aconitase uses an Fe-S cluster cofactor for its catalytic function (34) (35) (36) . Deficiencies in aconitase activity have been identified in heart biopsies of patients with FRDA, and similar deficiencies were identified in yeast strains lacking YFH1 (10) . We therefore assessed the incorporation of radioactive 55 Fe into aconitase in vivo, which has been used as an estimate of the presence of the Fe-S cluster in the enzyme (30) . We generated strains in which Aco1 was tagged at the C terminus with Myc (Aco1-Myc) and depleted Yfh1 as before, followed by a 4-hour pulse with 55 Fe. Consistent with the growth defect of YFH1-off in SC-lys-glu, 55 Fe content was substantially decreased in immunoprecipitated Aco1-Myc in YFH1-off compared to WT (Fig. 2D ). We also assessed aconitase activity in whole-cell extracts. Consistent with diminished Fe content in aconitase, enzymatic activity of aconitase was also markedly diminished following Yfh1 depletion (Fig. 2E ). However, H3H113N significantly restored 55 Fe content in Aco1-Myc ( Fig. 2D ) and aconitase activity to ~60% of normal levels ( Fig. 2E) , thereby corroborating the rescue of growth, amino acid synthesis defects, and functional Fe-S cluster abundance. We sought to determine whether the protective effect of the H3H113N mutation was restricted to amino acid synthesis or whether it generally protected Fe-S cluster-dependent function. We tested two disparate cellular processes: respiratory growth, which depends on numerous Fe-S clusters in the tricarboxylic acid cycle and in the electron transport chain (37) , and sensitivity to the DNA-damaging agent methyl methanesulfonate (MMS), which challenges the Fe-S cluster-dependent enzymes in the nucleus (38) . As expected, depletion of Yfh1 resulted in defective growth in medium containing nonfermentable carbon sources ethanol and glycerol (Fig. 2F ) and sensitivity to MMS (Fig. 2G ). H3H113N rescued YFH1-off in both contexts, consistent with a broad restoration of Fe-S cluster-dependent functions for various cellular processes (Fig. 2 , F and G). H3H113N prevents global transcriptional rewiring in response to defects in Fe-S cluster production Yfh1 depletion leads to widespread rewiring of gene expression, including induction of an iron deficiency response (39, 40) . We assessed gene expression profiles by mRNA sequencing and found substantial and reproducible alterations in YFH1-off in rich fermentative medium (Fig. 3A ). Approximately half of the yeast genome (2867 genes) was significantly differentially expressed in YFH1-off compared to WT (Fig. 3B) . However, H3H113N largely prevented most gene expression changes, consistent with the ability to rescue various defects resulting from Yfh1 and Fe-S cluster depletion (Fig. 3B) . For example, genes that were at least twofold significantly up-regulated (n = 280) (Fig. 3C ) or down-regulated (n = 214) (Fig. 3D ) in the YFH1-off strain were largely restored to their normal expression levels in H3 H113N YFH1-off. As expected, there was significant enrichment for genes involved in iron homeostasis, uptake, and transport among the significantly up-regulated genes in YFH1-off compared to WT ( fig. S5A) (39) . This is consistent with the function of the transcription factor Aft1, which activates many genes in response to the loss of Fe-S clusters (41, 42) . Correspondingly, among the significantly down-regulated genes in YFH1-off compared to WT, cellular processes that use Fe-S clusters as cofactors including the mitochondrial respiratory chain, tricarboxylic acid cycle, and amino acid synthesis were significantly enriched ( fig. S5A ). This finding is also consistent with previous investigations demonstrating that mRNA abundances of Fe-S cluster genes are generally diminished in concurrence with decreases in cellular iron abundance (43, 44) . Among the genes that were rescued by the H3H113N mutation, there was significant enrichment for genes involved in very similar functions, including iron homeostasis and amino acid synthesis (Fig. 3E) . Together, the fact that H3H113N prevented most of the transcriptional changes in YFH1-off, as opposed to specific subsets of genes, such as the lysine and glutamate synthesis genes, is consistent with H3H113N broadly preventing disruptions to Fe-S clusters instead of rescuing specific downstream processes. We considered more closely the expression of genes involved in iron mobilization and utilization, as well as the various Fe-S cluster assembly and target proteins. A majority of the Aft1 target genes displayed significantly elevated expression when Yfh1 was depleted ( Fig. 3B and fig. S5B ), which is consistent with the enrichment of this set of genes among all up-regulated genes in YFH1-off compared to WT (Fig. 3E) . The most highly induced Aft1 target genes were the cell wall mannoproteins FIT1, FIT2, and FIT3, as well as ARN1 and ARN2, which together mediate the uptake of siderophore-iron chelates from the environment (45, 46) . H3H113N ameliorated almost all the changes resulting from Yfh1 depletion ( Fig. 3B and fig. S5B ). As Aft1 responds to the abundance of Fe-S clusters (41) , this finding further suggests that H3H113N prevented Fe-S cluster disruptions. Many of the genes encoding for Fe-S cluster-binding proteins were also differentially expressed in response to Yfh1 depletion ( Fig. 3B and fig. S5C ). Several members of the mitochondrial Fe-S cluster assembly complex were up-regulated, including ISU1, ISU2, and NFS1 (Fig. 3B and fig. S5C ). Induction of these genes suggests a response by cells to compensate for diminished Fe-S cluster assembly in mitochondria. H3H113N almost entirely prevented the up-regulation of the Fe-S cluster assembly proteins in response to Yfh1 depletion ( Fig. 3B and fig. S5C ), indicating that the histone H3 mutation does not rescue YFH1-off by enhancing the process of Fe-S cluster assembly. Furthermore, genes encoding most other Fe-S cluster-binding proteins displayed significant downregulation in response to Yfh1 depletion ( Fig. 3B and fig. S5C ), in correspondence with decreased cellular Fe-S cluster abundance (43) . H3H113N mostly prevented the down-regulation of these genes ( Fig. 3B and fig. S5C ), further suggesting an ability to maintain functional Fe-S clusters despite a diminishment of Fe-S cluster assembly. Iron abundance, superoxide dismutase, and glutathione do not account for the protective effect of H3H113N when Fe-S cluster assembly is disrupted Previous studies have identified excessive iron accumulation as a major damaging component when frataxin/Yfh1 function is compromised (47) (48) (49) . Reduced abundance of cellular Fe-S clusters triggers the activation of Aft1, which, in turn, increases iron uptake from the environment. However, due to ineffective Fe-S cluster assembly in the absence of Yfh1, iron uptake does not effectively restore Fe-S cluster abundance. Instead, iron accumulates in the cell, including in mitochondria, which is proposed to become toxic (42) . In agreement with this, we observed that the growth defect of YFH1-off was rescued by the iron chelator bathophenanthrolinedisulfonate ( fig. S6A ). In addition, YFH1-off displayed sensitivity to highly elevated Fe concentration in media, which the H3H113N mutation ameliorated (fig. S6B ). To determine whether H3H113N was restoring function in YFH1-off by preventing iron accumulation, we generated additional strains in which FET3 was deleted (fet3). The Fet3 multicopper oxidase is part of the high-affinity iron uptake complex and, as an Aft1 target gene, substantially contributes to iron uptake (50) (51) (52) . Consistent with this, fet3 prevented the deterioration of growth of YFH1-off in both SC and SC-lys-glu media (Fig. 4A) . However, in contrast to the effect of H3H113N, fet3 could not sustain the growth of YFH1-off after several days on solid agar media (Fig. 4A) and did not rescue YFH1-off in liquid culture (Fig. 4B) . The H3 H113N YFH1-off fet3 triple mutant strain grew substantially more than YFH1-off fet3 in SC-lys-glu (Fig. 4A) , which suggests that H3H113N prevented the loss of function through a mechanism other than preventing iron uptake. To corroborate this finding, we examined cellular iron content in YFH1-off strains using inductively coupled plasma mass spectrometry (ICP-MS). Yeast strains were grown in liquid media for the shortest amount of time required for Yfh1 depletion to result in a growth defect in SC-lys-glu medium (and to avoid excessive cell death in the YFH1-off strain). This occurred after 44 hours of YFH1 shutoff (Fig. 4B) . Despite the rescue of YFH1-off growth defect by H3H113N, the cellular iron content in YFH1-off and H3 H113N YFH1-off was not significantly different (Fig. 4C) . Furthermore, deletion of FET3 decreased cellular iron content similarly in both strains (Fig. 4C) . These findings therefore indicate that H3H113N rescues YFH1-off independently of changes in total intracellular iron content. Fe-S clusters are also highly susceptible to oxidative damage (14, 16) . The Cu-Zn superoxide dismutase, Sod1, is a major contributor to antioxidant defense and is likely to protect Fe-S clusters from damage in the presence of oxygen (53) . We previously found that H3H113N diminishes Sod1 activity (24) . Nonetheless, in the unique context of YFH1-off and the resulting decrease of Fe-S clusters, we considered whether the restoration of function by H3H113N depended on Sod1. We generated additional strains in which SOD1 was deleted (sod1). Consistent with a protective function, sod1 exacerbated the deterioration of growth of YFH1-off in both SC and SC-glu media ( fig. S7A ). Note that we did not use SC-lys-glu medium because sod1 is a lysine auxotroph (54) . Critically, H3H113N was still able to restore function in the YFH1-off sod1 strain ( fig. S7A) , indicating that the H3H113N protective effects are independent of superoxide dismutase activity. Glutathione is also a crucial component of cellular redox balance and antioxidant defense. Reduced glutathione (GSH) can also contribute to the maturation of Fe-S cluster proteins (55) . Thus, we examined whether H3H113N prevented the dysfunction of YFH1-off by increasing the abundance of GSH. First, we assessed the cellular content of reduced and oxidized glutathione (GSH and GSSG, respectively) in cells growing exponentially in SC medium using MS. The H3 H113N strain did not display significant changes in abundance of GSH or GSSG ( fig. S7B) . Second, addition of as much as 1 mM exogenous GSH had no effect on the growth defect of YFH1-off or the rescue by H3H113N (fig. S7C ). Together, these observations indicate that the rescue of YFH1-off by the H3H113N mutation is unlikely to be related to glutathione abundance. Our finding that the H3H113N mutation results in resistance to copper toxicity (Fig. 1A) and that Cu 1+ ions are especially toxic to Fe-S clusters suggested that the broad rescue of YFH1-off by H3H113N was due to preventing copper toxicity. By the 44-hour time point, total cellular copper content had increased by ~35% in YFH1-off compared to WT (Fig. 5A ). This modest accumulation coincided with increased expression of copper mobilization and uptake genes, such as the main copper importer, CTR1 (56), which supports iron homeostasis (56) and may be a direct target of Aft1 ( fig. S8A) (57) . Conversely, total copper abundance did not change in H3 H113N YFH1-off compared to H3 H113N (Fig. 5A) . Addition of 10 M copper in SC-lys-glu resulted in substantially increased total cellular copper content in YFH1-off and even more so in H3 H113N YFH1-off ( fig. S8B ). Despite elevated copper accumulation, H3H113N still rescued the growth of YFH1-off in this media ( fig. S8C ). This indicates that the mechanism by which the H3H113N mutation restores Fe-S cluster homeostasis is not by diminishing total copper accumulation but rather by an impact on copper speciation, namely, a specific decrease in Cu 1+ abundance. To support the notion that H3H113N prevented Cu 1+ toxicity when Yfh1 was diminished, we tested whether depletion of total cellular copper would perform similarly. The presence of the copper chelator bathocuproine disulfonate (BCS) rescued the growth of YFH1-off and yfh1 in SC-lys-glu medium, similar to but to a lesser extent than the effect of H3H113N (Fig. 5B and fig. S8D ). Deletion of CTR1 also prevented the defect in YFH1-off albeit less robustly after several days of growth of YFH1-off cells ( fig. S8E ). The restoration of function by H3H113N was independent of CTR1, as the H3 H113N YFH1-off ctr1 triple mutant grew better than YFH1-off ctr1 (Fig. 5C) . These findings suggest that the decrease in Cu 1+ abundance specifically by H3H113N (24) is a distinct and more substantial protective effect for Fe-S clusters than merely diminishing total copper content. Last, H3H113N ameliorated the increased sensitivity of YFH1-off to excessive exogenous copper (Fig. 5D) , consistent with decreased Cu 1+ abundance. Together, our findings demonstrate the robust ability of the H3H113N mutation to prevent the deterioration of cellular function when Fe-S cluster assembly is compromised. Fe-S clusters are essential enzymatic or structural cofactors for proteins in many important cellular processes in eukaryotes. The assembly of Fe-S clusters is initiated in mitochondria followed by distribution throughout the mitochondria, cytoplasm, and nucleus. These cofactors, however, are highly vulnerable to damage by Cu 1+ ions through oxidative stress or direct displacement (14, 17, 22) . Disruption of Fe-S cluster homeostasis has been implicated in the pathogenesis of several human diseases ranging from cancer to neurodegeneration (3, (58) (59) (60) . Understanding the biological principles governing the production and decay of Fe-S clusters may therefore provide insights into human pathology and point to new therapeutic approaches. In this study, we found that Cu 1+ ions generated by the histone H3 cupric reductase activity function as key attrition factors against Fe-S clusters. This attrition could become toxic and result in metabolic and growth defects when Fe-S cluster assembly or distribution is compromised. Diminishment of Cu 1+ by impairment of the cupric reductase capability of histone H3 (24) restored Fe-S cluster-dependent functions when Fe-S cluster synthesis was inadequate, either due to decreased assembly (Fig. 1, B and C) or defective transport (Fig. 1, D and E) . Our findings thus reveal that Fe-S cluster deficiencies due to a variety of insults can be restored by diminishing histonemediated Cu 1+ production. This presents Cu 1+ depletion, for example, through inhibition of histone enzyme activity, as a potential therapeutic modality when Fe-S cluster homeostasis is disrupted. Together, our work reveals a previously unknown opposing relationship between histone H3 and mitochondria in maintaining appropriate levels of Fe-S clusters in the cell. Alterations of this balance may contribute to disease pathology but could potentially be restored at a lower but functioning level to mitigate disease phenotypes ( fig. S1 ). While copper ions support iron homeostasis in eukaryotes, such as through enzymes like Fet3 in yeast or ceruloplasmin in humans, Cu 1+ damages Fe-S clusters through oxidative stress and/or displacement. The precise mechanism by which the histone-dependent Cu 1+ production in the nucleus can become toxic to the cell, including mitochondria, remains unclear. One possibility is that nuclear Cu 1+ produced by histones that is normally trafficked to the mitochondria, in the context of disrupted Fe-S cluster assembly, damages the remaining cofactors in the mitochondria, in turn, impairing downstream Fe-S-dependent processes including amino acid synthesis. Another possibility is that histone-produced Cu 1+ causes damage locally to Fe-S cluster proteins in the nucleus, such as the DNA polymerases and Rad3 (61, 62) . To compensate, Fe-S clusters assembled elsewhere are redirected to replenish the various nuclear proteins but at the cost of compromising other Fe-S-dependent processes. A third possibility is that Cu 1+ toxicity is not limited to a subcellular location but occurs throughout the cell, with the loss of the most vulnerable Fe-S proteins manifesting as specific cellular phenotypes. Regardless of the mechanism of the damage, decreased histone H3 cupric reductase activity would diminish the production of Cu 1+ , decreasing the possibility of damage to Fe-S clusters locally in the nucleus or at distant sites in the cytoplasm or mitochondria. Future investigations that trace the pathways of copper flux, distribution, and homeostasis should help reveal the mechanisms underlying the dynamics of Cu 1+ -induced damage to Fe-S clusters. The fact that histones and the mitochondrial Fe-S cluster assembly complex are highly conserved across eukaryotes suggests that the histone H3-mediated Cu 1+ production may also become toxic in human disease with Fe-S cluster dysfunction. This prediction is especially relevant in diseases like FRDA and subtypes of sideroblastic anemia (63, 64) . FRDA is a neurodegenerative disease caused by triplet expansion mutations in the first intron of frataxin, the human homolog of Yfh1 (3). These genetic perturbations diminish frataxin expression, resulting in increased mitochondrial iron, decreased activity of Fe-S cluster enzymes, and greater oxidative stress (65) . Treatment with hypoxia can correct the various cellular defects resulting from frataxin loss and has been suggested as a potential therapeutic modality for FRDA (66) . Sideroblastic anemia with spinocerebellar ataxia (ASAT) is caused by mutations in ATP Binding Cassette Subfamily B Member 7 (ABCB7), a mitochondrial adenosine triphosphate-binding cassette transporter and the human homolog of yeast Atm1, which can export Fe-S cluster intermediates from mitochondria (67, 68) . At the cellular level, ASAT is characterized by aberrant mitochondrial iron homeostasis (69) . Our findings that H3H113N could protect against the dysfunction resulting from depletion of either Yfh1 or Atm1 implicate histone-dependent Cu 1+ toxicity as a possible pathogenic factor in FRDA and ASAT and potentially other diseases based on disrupted iron homeostasis. Our findings in yeast, if confirmed in studies of mammalian systems, also suggest possible new therapeutic opportunities. strains, the former of which was a gift from L. Kruglyak (71) . Strains are listed in table S1. Strains were generally maintained on YPD (1% yeast extract, 2% peptone, and 2% d-glucose) plates. However, strains with the GAL1 promoter placed upstream of YFH1, GRX5, or ATM1 were maintained on YPG (1% yeast extract, 2% peptone, and 2% galactose) plates. In addition, strains with CTR1 deleted were maintained on YPD/YPG plates supplemented with 20 M CuSO 4 (normal concentration is ~1 M Cu) before experiments. The additional copper was not present during experiments. Supplemental copper during routine streaking prevented the accumulation of defects in ctr1∆, thereby improving the reproducibility of experiments. All strains were grown at 30°C in all experiments. The H3H113N mutation was generated in both chromosomal loci (HHT1 and HHT2) using the CRISPR-Cas9 system optimized for S. cerevisiae (72) . For strains in fig. S3D , the H113N mutation was also reversed back to the WT sequence using CRISPR-Cas9. Subsequent gene deletions and promoter insertions were generated by standard yeast gene replacement and targeted insertion methodology using selectable marker integration (73) . Successful integrations and deletions were confirmed by polymerase chain reaction. The CUP1 gene was disrupted by the introduction of a stop codon at Phe 8 at all CUP1 copies using the CRISPR-Cas9 system. Strains in which YFH1 was deleted were phenotypically unstable. Within a few days following the transformation to replace YFH1 with a selectable marker, clones would often spontaneously recover growth rates. Therefore, for the experiments shown in Fig. 1B and figs. S4B and S8D , yfh1 strains were used immediately following transformation and were not stored long-term. In all other cases, standard yeast culturing procedures were followed, and strains were continuously maintained on YPD or YPG plates, restreaking cells every 2 weeks for a maximum of four times. Removal of contaminating metals from glassware and solutions is a critical precaution to ensure reproducibility of experiments. All glassware was treated with 3.7% hydrochloric acid for ≥12 hours, followed in some cases by ≥12 hours with 7% nitric acid to remove trace metal contamination. All solutions, buffers, and washes were prepared using Milli-Q (Millipore Sigma) ultrapure water. Solutions were prepared using BioUltra grade (Sigma-Aldrich) reagents, when available. For yeast media, addition of all components was done without the use of metal spatulas. Media were filtered through 0.2-m membranes. Fermentative media were SC (SC medium with 2% glucose, all amino acids, and uracil and adenine), SC lacking lysine or glutamate, or minimal medium (with 2% glucose and either no amino acids or only essential auxotrophic metabolites). Agar media were prepared using acid-washed glassware. Cells from exponentially growing cultures were fourfold serially diluted and spotted on various media conditions as indicated in the figures. For experiments in which the GAL1 promoter was used to shut off expression for 1, 2, or 3 days, cells on YPG were inoculated into SC medium and grown for approximately 15 hours (day 1). For 2 and 3 days of shutoff, cultures were grown for an additional 48 hours in SC and diluted to optical density at 600 nm (OD 600 ) = 0.05 every 24 hours. Cells were allowed to grow for an additional 4 hours to enter exponential growth phase, at which point they were collected for spotting. Spotted plates were incubated at 30°C for up to 4 days and imaged daily. Images shown in the figures were captured when sufficient growth had occurred and growth differences could be assessed (2 to 4 days). For the experiment in Fig. 2A , plates with gradually decreasing amounts of SC amino acid powder (Sunrise Science Products) were prepared while keeping all other components the same [2% glucose, yeast nitrogen base (1.7 g/liter), and ammonium sulfate (5 g/liter)]. For aconitase assay, ICP-MS, and RNA sequencing (RNA-seq) analyses, YFH1-off cells on YPG were inoculated into SC medium at OD 600 = 1 and grown for 36 hours in a 30°C shaker, diluting to OD 600 = 1 every 12 hours. After 36 hours, cells were diluted once more to OD 600 = 1 in either SC or SC-lys-glu and grown for a further 8 hours (44 hours in total) or for 5 hours in the experiment in fig. S8B . Cells were then processed for downstream assays. Aconitase assay Cellular aconitase activity was assessed using the Aconitase Activity Assay Kit (Sigma-Aldrich, MAK051-1KT), and the manufacturer's protocol was followed with minor adjustments. Spheroplasts were lysed in 200 l of assay buffer, centrifuged at 13,000g for 10 min at 4°C, and the supernatant (i.e., the lysate) was recovered. Protein concentration was determined using the BCA Protein Assay Kit (Pierce), and 900 g of protein was diluted into a final volume of 100 l in assay buffer containing 1× Protease Inhibitor Cocktail (Pierce). Ten microliters of freshly prepared Activator Solution (following the manufacturer's protocol) was added to the samples and incubated for 1 hour on ice. Fifty microliters of activated lysate was then mixed with 50 l of reaction mix, which contains either enzyme and substrate or enzyme alone (for background correction). The reaction was incubated for 1 hour at 25°C, after which 10 l of developer solution was added to each sample and incubated for another 10 min at 25°C. Absorbance at 450 nm was determined, background was subtracted, and the absorbance readings were converted to product concentration (millimolars of isocitrate) using a standard curve as described by the manufacturer. Standard Western blot methodology was used to detect protein content from whole-cell extracts, with the exception of Yfh1-myc. For Yfh1-myc, a crude mitochondrial extract was prepared as previously described (74) , except that the final pellet was resuspended in radioimmunoprecipitation assay buffer [150 mM NaCl/50 mM tris-HCl (pH 8)/1% NP-40 (Ipegal), 0.5% Na-deoxycholate/0.1% SDS]. Primary antibody against Myc (Millipore, catalog no. 05-419, lot no. 3713344) was used at a 1:2000 dilution. Primary antibody against Mia40 was a gift from C. Koehler and was used at a 1:10,000 dilution. Primary antibody against -actin (Abcam, catalog no. ab170325, lot no. GR3371939-5) was used at a 1:5000 dilution. Cells harboring a Myc-tagged Aco1 were grown in SC-galactose for 16 hours or SC-glucose for 36 hours before being switched to the same media lacking iron for 13 hours. Labeling with 55 Fe was then performed as previously described (75) , except that Aco1-Myc was immunoprecipitated using 25 l of anti-Myc magnetic beads (Pierce, catalog no. 88842, lot no. WA314853) incubated with 250 l of labeled lysate. Cells from the 44-hour cultures (YFH1-off and H3 H113N YFH1-off), or exponentially growing cells (WT and H3 H113N ), were collected by centrifugation and frozen at −20°C until processed for RNA extraction and RNA-seq. RNA was extracted using previously published methods (76) . RNA extracted for subsequent RNA-seq analysis is from four replicate experiments. Before preparing RNA-seq libraries for Illumina NovaSeq sequencing, contaminating DNA was digested using Turbo™ DNase (Thermo Fisher Scientific). RNA quality was then assessed on a 1% agarose gel to confirm minimal RNA degradation. RNA-seq libraries were then prepared with the KAPA mRNA Hyper Prep Kit (Kapa Biosystems) according to the manufacturer's protocols. RNA-seq libraries were assessed for correct fragment size and the presence of adapter dimers by running on a 1% agarose gel. Average library sizes of ~270 base pairs were generated. Libraries were pooled for multiplexed sequencing and further purified using KAPA Pure beads. Total DNA concentration was adjusted to 10 nM for Illumina sequencing. High-throughput sequencing was performed on Illumina's NovaSeq system. Total read count per library ranged from ~8 million to 14 million. Demultiplexed reads, in FASTQ file format, were processed to check for read and genome alignment quality and to convert reads to normalized gene counts (https://training.galaxyproject. org/training-material/topics/transcriptomics/tutorials/rna-seqreads-to-counts/tutorial.html) (77) . Processing steps included the assessment of raw read quality using FastQC and genome alignment in strand-specific manner to the R64-1-1 S288C reference genome assembly (sacCer3) using HISAT2 (78) . Assigning and counting reads for 6692 annotated open reading frames were performed using featureCounts (79) . Determination of adjusted P values for differential gene expression comparisons was done using DESeq2 (https://bioconductor.org/packages/release/bioc/vignettes/DESeq2/ inst/doc/DESeq2.html) (80) . Principal components analysis was performed using a built-in function as part of the DESeq2 package. Significantly differentially expressed genes (adjusted P < 0.05) identified by DESeq2 were assessed for Gene Ontology term enrichment using the Database for Annotation, Visualization, and Integrated Discovery (81, 82) with default parameters. Gene sets for gene expression visualization in heatmaps were constructed by downloading Gene Ontology term gene lists from AmiGO 2 in March 2017. Inductively coupled plasma mass spectrometry Cells (8 × 10 8 ) from the 44-or 41-hour cultures (YFH1-off strains) or exponentially growing cells (WT and H3 H113N ) were collected and washed twice in 5 mM EDTA, to remove cell surface-associated metals, and once in Milli-Q water. Cell pellets were stored at −20°C until further processed for ICP-MS. Cell pellets were overlaid with 143 l of 70% nitric acid (Fisher, Optima grade, A467-500, lot 1216040) and digested at room temperature for 24 hours, followed by incubation at 65°C for about 4 hours, and lastly being diluted to a final nitric acid concentration of 2% (v/v) with Milli-Q water. Iron and copper contents were determined by ICP-tandem MS (MS/MS) on an Agilent 8900 Triple Quadrupole ICP-MS/MS instrument, in comparison to an environmental calibration standard (Agilent, 5183-4688), using 89 Y as an internal standard (Inorganic Ventures, MSY-100PPM). The levels of all analytes were determined in MS/MS mode, where 63 Cu was measured directly using He in the collision reaction cell, and 56 Fe was directly determined using H 2 as a cell gas. The average of three to five technical replicate measurements was used for each individual biological replicate. The average variation between technical replicate measurements was 1.4% for all analytes and never exceeded 5% for an individual sample. All Cu and Fe measurements were within the calibrated linear ranges and above the lower limits of detection, as determined from multiple blank samples. ICP MassHunter software was used for ICP-MS data analysis. Cells (6 × 10 8 ) from exponentially growing cultures were collected by centrifugation. The cells were washed once in a 43% ice-cold methanol-water solution. To extract the metabolites, the washed cells were resuspended in 200 l of ice-cold (stored at −80°C) 80% methanol containing 10 nM trifluoromethanesulfonate (TFMS). The resuspended cells were vortexed for 5 s, frozen immediately in liquid nitrogen for 5 min, and then allowed to thaw in an ice bath for 5 min. The cells were pelleted at 16,000g to collect the supernatant. The cell pellet was resuspended in another 100 l of methanol-TFMS solution and pelleted to collect the supernatant. The combined supernatant was dried under vacuum, and the dried metabolites were stored at −80°C until MS analysis. Extracted dried metabolites were reconstituted in a 50% acetonitrile and 50% dH 2 O solution and processed further for analysis by MS as previously described (83) . The number of experimental replicates (n) and the observed significance levels are indicated in the figure legends. All statistical analyses were performed using R version 4.0.0, including use of the DESeq2 package, as described above. For most pairwise comparisons, F tests were first performed to determine whether group variances were significantly different. When variances were not different, P values for group differences were determined with the two-sample unpaired t test. When variances were significantly different, P values were determined with the Welch two-sample t test. For pairwise comparisons of ≥2-fold up-regulated or down-regulated genes (Fig. 3, C and D) , expression values (normalized read counts) were first averaged across the four biological replicates, transformed into log 10 scale, and P values were determined with the paired t test. Supplementary material for this article is available at https://science.org/doi/10.1126/ sciadv.abj9889 View/request a protocol for this paper from Bio-protocol. Iron-sulfur clusters: Nature's modular, multipurpose structures Function and biogenesis of iron-sulphur proteins Friedreich's ataxia: Autosomal recessive disease caused by an intronic GAA triplet repeat expansion Mrs3p, Mrs4p, and frataxin provide iron for Fe-S cluster synthesis in mitochondria Evidence for a conserved system for iron metabolism in the mitochondria of Saccharomyces cerevisiae Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin Iron-sulfur cluster biosynthesis in bacteria: Mechanisms of cluster assembly and transfer The yeast frataxin homolog Yfh1p plays a specific role in the maturation of cellular Fe/S proteins Inhibition of Fe-S cluster biosynthesis decreases mitochondrial iron export: Evidence that Yfh1p affects Fe-S cluster synthesis Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia Frataxin acts as an iron chaperone protein to modulate mitochondrial aconitase activity The fungal -aminoadipate pathway for lysine biosynthesis requires two enzymes of the aconitase family for the isomerization of homocitrate to homoisocitrate Aconitase couples metabolic regulation to mitochondrial DNA maintenance Micromolar intracellular hydrogen peroxide disrupts metabolism by damaging iron-sulfur enzymes Interplay between oxygen and Fe-S cluster biogenesis: Insights from the Suf pathway Cellular defenses against superoxide and hydrogen peroxide Anaerobic copper toxicity and iron-sulfur cluster biogenesis in Escherichia coli Copper-induced oxidative stress in Saccharomyces cerevisiae targets enzymes of the glycolytic pathway Copper toxicity towards Saccharomyces cerevisiae: Dependence on plasma membrane fatty acid composition Copper metallochaperones ] cluster assembly in mitochondria and its impairment by copper The iron-sulfur clusters of dehydratases are primary intracellular targets of copper toxicity Mitochondrial ferredoxin determines vulnerability of cells to copper excess The histone H3-H4 tetramer is a copper reductase enzyme Yeast metallothionein. Sequence and metal-binding properties Tandem gene amplification mediates copper resistance in yeast The mitochondrial protein frataxin prevents nuclear damage Grx5 is a mitochondrial glutaredoxin required for the activity of iron/sulfur enzymes The mitochondrial Hsp70 chaperone Ssq1 facilitates Fe/S cluster transfer from Isu1 to Grx5 by complex formation The mitochondrial proteins Atm1p and Nfs1p are essential for biogenesis of cytosolic Fe/S proteins Glutamate synthase from Escherichia coli. An iron-sulfide flavoprotein Specialized function of yeast Isa1 and Isa2 proteins in the maturation of mitochondrial [4Fe-4S] proteins Sulfite reductase structure at 1.6 A: Evolution and catalysis for reduction of inorganic anions On pig heart aconitase The soluble "high potential" type iron-sulfur protein from mitochondria is aconitase Structure of activated aconitase: Formation of the [4Fe-4S] cluster in the crystal Maturation of iron-sulfur proteins in eukaryotes: Mechanisms, connected processes, and diseases A role for iron-sulfur clusters in DNA repair Mitochondrial control of iron homeostasis. A genome wide analysis of gene expression in a yeast frataxin-deficient strain AFT1: A mediator of iron regulated transcriptional control in Saccharomyces cerevisiae Transcription of the yeast iron regulon does not respond directly to iron but rather to iron-sulfur cluster biosynthesis Identification of FRA1 and FRA2 as genes involved in regulating the yeast iron regulon in response to decreased mitochondrial iron-sulfur cluster synthesis Coordinated remodeling of cellular metabolism during iron deficiency through targeted mRNA degradation Cooperation of two mRNA-binding proteins drives metabolic adaptation to iron deficiency Three cell wall mannoproteins facilitate the uptake of iron in Saccharomyces cerevisiae Desferrioxamine-mediated iron uptake in Saccharomyces cerevisiae Deletion of the yeast homologue of the human gene associated with Friedreich's ataxia elicits iron accumulation in mitochondria Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin Direct evidence that mitochondrial iron accumulation occurs in Friedreich ataxia A permease-oxidase complex involved in high-affinity iron uptake in yeast The FET3 gene of S. cerevisiae encodes a multicopper oxidase required for ferrous iron uptake Iron-regulated DNA binding by the AFT1 protein controls the iron regulon in yeast Yeast lacking Cu-Zn superoxide dismutase show altered iron homeostasis. Role of oxidative stress in iron metabolism Suppression of oxidative damage by Saccharomyces cerevisiae ATX2, which encodes a manganese-trafficking protein that localizes to Golgi-like vesicles Glutaredoxins and iron-sulfur protein biogenesis at the interface of redox biology and iron metabolism Biochemical characterization, regulation by copper, and physiologic role in copper uptake An improved map of conserved regulatory sites for Saccharomyces cerevisiae Breast cancer tumorigenicity is dependent on high expression levels of NAF-1 and the lability of its Fe-S clusters Dysregulation of iron metabolism in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis Iron-sulfur cluster biogenesis and human disease The DNA repair helicases XPD and FancJ have essential iron-sulfur domains An iron-sulfur cluster in the polymerase domain of yeast DNA polymerase  Glutaredoxin 5 deficiency causes sideroblastic anemia by specifically impairing heme biosynthesis and depleting cytosolic iron in human erythroblasts The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts Iron-sulfur cluster synthesis, iron homeostasis and oxidative stress in Friedreich ataxia Hypoxia rescues frataxin loss by restoring iron sulfur cluster biogenesis Mitochondria export iron-sulfur and sulfur intermediates to the cytoplasm for iron-sulfur cluster assembly and tRNA thiolation in yeast Defining the mechanism of the mitochondrial Atm1p Mutation of a putative mitochondrial iron transporter gene (ABC7) in X-linked sideroblastic anemia and ataxia (XLSA/A) Designer deletion strains derived from Saccharomyces cerevisiae S288C: A useful set of strains and plasmids for PCR-mediated gene disruption and other applications Finding the sources of missing heritability in a yeast cross Selection of chromosomal DNA libraries using a multiplex CRISPR system Additional modules for versatile and economical PCR-based gene deletion and modification in Saccharomyces cerevisiae Isolation of yeast mitochondria Analysis of iron-sulfur protein maturation in eukaryotes A rapid and simple method for preparation of RNA from Saccharomyces cerevisiae Community-driven data analysis training for biology Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype featureCounts: An efficient general purpose program for assigning sequence reads to genomic features Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition